Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 4, Issue 11, Pages 1908-1937
Publisher
MDPI AG
Online
2015-11-11
DOI
10.3390/jcm4111908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole
- (2014) Jerry Yee ADVANCES IN CHRONIC KIDNEY DISEASE
- Blood Pressure, Hypertension, RAAS Blockade, and Drug Therapy in Diabetic Kidney Disease
- (2014) Hala Yamout et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Sequential RAAS Blockade: Is It Worth the Risk?
- (2014) Frederik Persson et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy
- (2014) P. N. Van Buren et al. Clinical Journal of the American Society of Nephrology
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD
- (2013) Sandra J. Taler et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- US Renal Data System 2013 Annual Data Report
- (2013) Allan J. Collins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes
- (2013) Rudy Bilous ANNALS OF INTERNAL MEDICINE
- Is there benefit in dual renin– angiotensin–aldosterone system blockade? No, yes and maybe: A guide for the perplexed
- (2013) Jencia Wong Diabetes & Vascular Disease Research
- Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy
- (2013) Thomas A. Mavrakanas et al. European Journal of Internal Medicine
- Effects of dual blockade of the renin–angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT–Hypertension)
- (2013) Enyu Imai et al. HYPERTENSION RESEARCH
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
- (2013) David C. Wheeler et al. KIDNEY INTERNATIONAL
- The effect of RAAS blockade on the progression of diabetic nephropathy
- (2013) Sara S. Roscioni et al. Nature Reviews Nephrology
- Evidence of the syndrome of rapid onset end-stage renal disease (SORO-ESRD) in the acute kidney injury (AKI) literature – preventable causes of AKI and SORO-ESRD – a call for re-engineering of nephrology practice paradigms
- (2013) Macaulay A.C. Onuigbo RENAL FAILURE
- Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
- (2013) Masako Furukawa et al. TheScientificWorldJOURNAL
- Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia
- (2013) Ta-Wei Hsu et al. JAMA Internal Medicine
- Retraction
- (2012) HEART
- Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus
- (2012) George L. Bakris et al. Journal of Clinical Hypertension
- Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers
- (2012) Hiddo J. Lambers Heerspink et al. KIDNEY INTERNATIONAL
- Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases
- (2012) E. Morales et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Foreword
- (2012) Kidney International Supplements
- Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis
- (2011) Yoko M. Nakao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
- (2011) Jennifer A. Hirst et al. KIDNEY INTERNATIONAL
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Renin-Angiotensin-Aldosterone System Blockade for Diabetic Kidney Disease
- (2010) Raimund H. Pichler et al. Current Diabetes Reports
- Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?
- (2010) J. Wong et al. DIABETES OBESITY & METABOLISM
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD
- (2010) Macaulay A.C. Onuigbo RENAL FAILURE
- Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade
- (2009) Nitin Khosla et al. AMERICAN JOURNAL OF NEPHROLOGY
- Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
- (2009) L. F. Fried et al. Clinical Journal of the American Society of Nephrology
- Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes
- (2009) I. H. de Boer et al. DIABETES CARE
- Supramaximal Dose of Candesartan in Proteinuric Renal Disease
- (2009) E. Burgess et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
- (2009) B. E. de Galan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
- (2009) Bruce A. Perkins et al. KIDNEY INTERNATIONAL
- Radiographic Contrast-Induced Nephropathy and Patient Mortality–2
- (2009) Macaulay A.C. Onuigbo MAYO CLINIC PROCEEDINGS
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review
- (2008) Andrew S. Bomback et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
- (2008) L. Vogt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
- (2008) F. Persson et al. KIDNEY INTERNATIONAL
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis
- (2008) M.A.C. Onuigbo et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started